Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Theravance, Inc. 

901 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-808-6000 Fax: 650-827-8690



 Company News
Theravance, Inc. (THRX) Appoints Eric d'Esparbes As Senior Vice President And Chief Financial Officer 10/10/2014 9:33:57 AM
Theravance, Inc. (THRX) Release: Data Published On Anoro® Ellipta® Demonstrate Improved Lung Function Compared To Tiotropium 10/8/2014 2:20:52 PM
Theravance, Inc. (THRX) Announces Positive Top-Line Results From Phase 2b Dose-Ranging Study Of Its Investigational LAMA, TD-4208, For The Treatment Of COPD 9/9/2014 11:16:24 AM
Theravance, Inc. (THRX) Provides VIBATIV® (telavancin) Product Update 9/9/2014 11:13:59 AM
Theravance, Inc. (THRX) To Present At The Baird 2014 Health Care Conference 8/22/2014 11:01:44 AM
Theravance, Inc. (THRX) Reports Second Quarter 2014 Financial Results 8/7/2014 10:57:59 AM
South San Francisco's Theravance, Inc. (THRX) Brings In A New CEO 8/6/2014 3:50:47 PM
Theravance, Inc. (THRX) To Report Second Quarter 2014 Financial Results On August 6, 2014 7/31/2014 12:45:46 PM
GlaxoSmithKline (GSK), Theravance, Inc. (THRX) Begin Pivotal Phase 3 Trial For Triple Combination Treatment 7/16/2014 7:42:21 AM
Theravance, Inc. (THRX) Release: Anoro® Ellipta® (Umeclidinium/Vilanterol) Gains Approval In Japan For The Treatment Of COPD 7/7/2014 12:28:54 PM